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Toxicity of Platinum (IV) Salts for
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by Michael D. Waters,* T. Owens Vaughan,* Diane J.
Abernethy,* Helen R. Garland,* Christine C. Cox,*
and David L. Coffin*
The acute toxicity of tetravalent platinum was studied in vitro by use ofrabbit alveolar
macrophages and human lung fibroblasts (strain WI-38). Alveolar macrophages were ex-
posed in tissue culture for 20 hr to platinum dioxide (PtO2) or platinum tetrachloride
(PtCl4). There was no evidence ofdissolution ofPtO2 and no decrease in viable cells at con-
centrations as high as 500 ,ug/ml. PtC14 was soluble in the macrophage system and after a
20-hr exposure, resulted in loss of viability in 50% of the cells originally present at a con-
centration of 0.30rnM (59 ,ug Pt/ml). After a 20-hr exposure, rapidly growing human lung
fibroblasts were rendered nonviable by PtCl4 at comparable concentrations. A decrease in
total cellular ATP was observed at lower concentrations in macrophages and fibroblasts
along with a reduction in phagocytic activity ofmacrophages as compared to controls. With
the fibroblasts, a 50% decrease in incorporation of14C-thymidine was observed after a 22-hr
exposure to PtCl4 at a concentration of0.007mM; higher concentrations were required to in-
hibit the incorporation of 14C-uridine and 14C-leucine.
Time-course studies indicated that the inhibition of 14C-thymidine incorporation was
nearly complete (90%) after 7 hr in the prepence of 0.06mM PtC14. Under the same condi-
tions, there was little inhibition (15%) of 14C-leucine incorporation and moderate inhibition
(50%) of 14C-uridine incorporation. Higher concentrations ofPtCl4 were required to inhibit
14C-thymidine incorporation into the acid-soluble fraction than were required to inhibit in-
corporation into the acid-precipitable fraction. Hence, the preferential inhibition of DNA
synthesis by PtCl4 may result from an impairment of the incorporation process.
Introduction
The increasing usage of platinum and its com-
pounds, particularly as the active component ofthe
automotive catalytic converter, has stimulated
renewed interest in the pulmonary toxicology of
this metal. The principal clinical manifestation of
inhalation of complex salts of platinum, mainly
chloroplatinates, is an allergic disease termed
platinosis. Parrot et al. (1) have suggested that the
release ofhistamine with intense bronchospasm ob-
served in guinea pigs exposed to sodium
chloroplatinate may mimic the asthmatic response
seen in platinum workers. The principal difference
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between the response seen in man and that ob-
served in the experimental animal is related to
time. Exposure for 2-6 months in the refining
workshop is required before the onset of asthma,
eczema, or urticaria. Approximately one half or
more of those individuals heavily exposed to the
complex salts demonstrated such a delayed
response (1). Hence, it has been proposed that salts
of platinum may combine in the body with a pro-
tein to form a complex antigen or haptene (1).
Other known interactions of platinum metals and
their complexes in biological systems have been
reviewed recently by LeRoy (2).
The present investigation was undertaken to
further examine an additional aspect of platinum
toxicology which has developed from studies with
platinum antitumor agents. These studies have
December 1975 45demonstrated a correlation between antitumor po-
tency and the effectiveness of these compounds in
inhibiting DNA synthesis in mammalian cells in
culture (3). Therefore, it was of interest to examine
the cytotoxic properties of relatively insoluble and
soluble platinum compounds in both nondividing
and rapidly dividing cells of pulmonary origin.
Materials and Methods
Cell Culture
The techniques associated with the procurement
and maintenance of rabbit alveolar macrophages
have been previously described (4). For the present
studies, replicate cultures of macrophages were
established in 25 cm2 Falcon plastic flasks (4 ml at
5 x 105 cells/ml) and allowed to attach in a
humidified atmosphere at 96% air and 4% C02 at
370C, 3 hr being allowed for attachment of cells in
the stationary cultures. Unattached cells (approx-
imately 15% of the inoculum) were then poured
off and platinum compounds were added in fresh
medium.
Platinum dioxide (K & K Laboratories, Inc.,
Plainview, N.Y.) was added directly to supple-
mented Medium 199 in Hanks' balanced salt solu-
tion at pH 7.2. Platinum tetrachloride (K & K
Laboratories, Inc.) was added to supplemented
Medium 199, adjusted to pH 7.2 with ultrapure
NaOH (Alpha Inorganics, Ventron; Beverly,
Mass.) and filtered through a 0.22 um Millipore
filter. An aliquot was removed for atomic absorp-
tion spectrophotometry, and appropriate dilutions
were made with additional supplemented medium.
Human lung fibroblasts in passage 17 were ob-
tained from the American Type Culture Collection,
Rockville, Maryland and were maintained in 75
cm2 Falcon flasks. Cultures were subcultivated
twice weekly by use of 0.25% trypsin in Gibco solu-
tion A with a 1:2 split ratio. Cultures were seeded
at 1.75 x 105 cells/ml (4.0 ml total volume) in 25
cm2 Falcon flasks and maintained in Basal
Medium Eagle (BME) with Earles salts plus 10%
fetal bovine serum (virus screened), 2 ,amole/ml L-
glutamine, 100 units/ml penicillin, 100,ug/ml strep-
tomycin, and 2.5 ,tg/ml amphotericin-B. Growth
curves were established for cells in passages 22 and
33 (see results). Experiments were performed dur-
ing the period ofrapid growth from 24 to 72 hr after
subcultivation.
Platinum tetrachloride was added directly to
BME, and the pH was adjusted to 7.2 prior to
Millipore filtration as previously described for
macrophage cultures.
All tissue culture media and supplemnents were
obtained from Grand Island Biological Company,
Grand Island, New York.
Metal Analysis
Analysis of actual platinum concentrations in
stocks of test media was performed on a Perkin-
Elmer model 306 atomic absorption spectro-
photometer equipped with a model HGA-2100
graphite furnace. Nitrogen was used as the purge
gas at a flow pressure of 50 psi. Automatic sample
processing in the graphite furnace included drying
at 100°C for 34 sec, charring at 10500C for 30 sec,
and atomization at 27000C for 8 sec. Standards
were prepared in supplemented tissue culture
media from chloroplatinic acid, 1000 ppm (Alfa In-
organics, Ventron), immediately prior to sample
analysis. Absorbance was linear with respect to
platinum concentration at levels of 5 ppm or less.
Samples were diluted so that absorbance was with-
in the linear range observed with standards.
Viability Determinations
Viability determinations were performed as
follows. The culture medium was poured off and
retained separately in a culture tube. Cells were
dissociated by using 0.25% trypsin in Gibco solu-
tion A. The suspended cells were recombined with
the original culture medium and chilled. Appropri-
ate dilutions, usually 4-fold, were made by using
cold 0.85% saline to yield a suspension of no more
than 2 x 105 cells/ml. Trypan blue, freshly diluted
with 0.85% saline to a final concentration of
0.01%, was added to an equal volume of cell
suspension for determination of cell viability.
Simultaneous determinations of cell viability and
cell numbers per milliliter of cell suspension were
performed by using the Cytograf Model 6301
(Biophysics Systems, Mohapac, N.Y.). Viability
was expressed directly as a percentage. The
viability of cells from control cultures was
routinely 95% or greater. Cell numbers were ex-
pressed as a percentage of the numbers of cells in
control cultures. Viability determinations were
multiplied by total cell numbers as a fraction of
control cell numbers to yield the viability index, or
net number of viable cells as a per cent of control.
Viability index = Viability (% ) x No. cells exptl
No. cells control
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Phagocytic activity following a 19-hr exposure
to platinum tetrachloride was measured by addi-
tion of 1.1 ,um polystyrene latex particles (Dow
Diagnostics, Indianapolis, Indiana) to alveolar
macrophages cultured in Lab-Tek (Miles
Laboratories, Inc., Naperville, Ill.) four-chamber
microslides (approximately 25 particles/cell in 1 ml
of supplemented medium). Preparation and main-
tenance conditions were as previously described for
flask cultures. One hour after the addition of latex
particles, the slides were drained, air-dried, and ex-
posed for 3 min to concentrated Wright stain. The
slides were then exposed for an additional 5-6 min
with a 1:1 aqueous dilution ofWright's stain. After
air drying, the slides were placed in xylene for 1 hr
to dissolve extracellular particles accordihg to the
procedure ofGardner et al. (5). Following an addi-
tional drying step, the slides were mounted in per-
mount. Phagocytic activity was determined under
oil immersion by scoring a minimum of 200 cells.
Each cell which contained at least one particle was
considered phagocytically active. Typically,
80-90% of the cells in control cultures ingested
one or more particles.
Adenosine Triphosphate Determina-
tion
ATP was determined according to a procedure
supplied with the DuPont model 760 Luminescence
Biometer. Dimethyl sulfoxide (0.9 ml) was used to
extract ATP from a 0.1-ml aliquot of trypsinized
cellsuspension containing 0.3-0.4 x 105cells. After
2 min at room temperature, 5.0 ml of cold 0.01M
morpholinopropane sulfonic acid (MOPS) at pH
7.4 was added to buffer the extracted sample. The
tube containing the buffered sample was then
placed in an ice bath. Aliquots of 10 ,ul were in-
jected into the luminescence meter's reaction
cuvette containing 0.7mM luciferin (crystalline),
100 units luciferase (purified and stabilized),* and
0.01M magnesium sulfate in a total volume of 100
gl of 0.01M MOPS buffer, pH 7.4 at 25°C. Light
emitted from the reaction cuvette was measured
photometrically in the luminescence meter and was
proportional to the ATP concentration of the sam-
ple.
*Unit (1) luciferase = response to 1.64umole ATP
response to 2() jiCi -C calibrated
light source
For determination of total culture protein, cells
washed twice with 0.85% saline were lysed in 1.0%
sodium deoxycholate (Schwarz-Mann,
Orangeburg, New York) and 0.1 ml aliquots were
assayed according to the method ofLowry et al. (6)
by using a bovine serum albumin standard (Nutri-
tional Biochemicals Corp., Columbus, Ohio).
Deoxyribonucleic Acid Assay
DNA was determined on a 0.2 ml aliquot of 1%
sodium deoxycholate lysate according to a
modification of the procedure of Kissane and
Robins (7). In brief, the details ofthis modification
are as follows. The sample is precipitated in a 10 x
75 mm disposable glass tube by addition of 0.2 ml
of 10% trichloroacetic acid without mfixing. The
precipitate is sedimented by centrifugation, and the
supernatant fluid is carefully removed by aspira-
tion. A volume of0.2 ml of 0.1M potassium acetate
in absolute ethanol is added to the precipitate and
allowed to stand without mixing for 5-10 min. The
precipitate is again centrifuged and the potassium
acetate solution is carefully removed by aspiration.
A 20-pLI portion of 2.OM 3,5-diaminobenzoic acid in
4.ON HCl is added and vigorously mixed with the
precipitated sample by vortexing. The tubes are
stoppered and incubated in a water bath at 60°C
for 30 min. After this time, the tubes are removed,
the samples cooled to room temperature, and 0.75
ml of 0.6N perchloric acid is added to each sample
with mixing. The tubes are centrifuged to remove
floating particles and the supernatant liquid is
transferred by means of a pasteur pipet to cuvettes
for reading. Disposable glass cuvettes, 6 x 50 mm
(DuPont Instruments, Wilmington, Delaware),
were used in the present study. A Perkin-Elmer
model 204 fluorescence spectrophotometer fitted
with microcuvette adaptors was employed with an
excitation wave length of 415 nm and an emission
wavelength of 495 nm.
Radiochemical Assays
Solutions ofthymidine-2-14C, uridine-2-14C, and
leucine-1-14C (New England Nuclear Corp., Boston
Massachusetts), each having a specific radioac-
tivity of 54-57 mCi/mmole, were diluted in supple-
mented BME with Earle's salts and added at
0.5,Ci/0.1 ml to a 4.0 ml volume of medium in 25
cm2 Falcon flasks. In all incorporation studies,
radiochemicals were present for 2 hr only. After
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47this time, cultures were placed on ice and washed
twice with 4 ml of ice-cold 0.85% sodium chloride.
Cultures were thoroughly drained, and 2.0 ml of
ice-cold 1.0% sodium deoxycholate was added to
lyse the cells. Aliquots (0.2 ml) of the lysate were
removed and transferred to 15 ml ofAquasol (New
England Nuclear Corp.) for liquid scintillation
counting oftotal cellular uptake radioactivity. The
remaining lysate was stored frozen at -20°C. Upon
thawing, aliquots (0.2 ml) were removed to test
tubes and precipitated with 3 ml of ice-cold 1.07N
perchloric acid (PCA). The precipitates were
poured onto 2.4-cm glass fiber filters (Reeve Angel,
Clinton, New Jersey) under vacuum and washed
twice out of the tube onto the filter with 3 ml of
cold 1.ON PCA. The precipitates were then washed
three times with 3 ml of ice-cold 70% ethanol, and
the filters were left to dry under vacuum. Filters
were then removed to scintillation vials. Aquasol
(15 ml) was added, and the vials were counted in a
Packard model 3380 Tricarb liquid scintillation
spectrometer using standard instrument settings
for carbon-14. Counting efficiency was 87-91%.
Counts per minute were corrected to disintegra-
tions per minute by use of the automatic external
standard ratio and validated quenched standards.
Disintegrations per minute per milliliter were
divided by total protein per milliliter to correct for
differences in numbers of cells per culture.
Statistics
All ofthe above determinations were performed
in duplicate or triplicate. Since cell viability could
be considered a binomial response, the arc-sine
transformation was employed in the regression
analysis (8). This technique helped to linearize the
data when viability, as a percentage, was plotted
versus the natural logarithm of the molar con-
centration. Other cytofunctional and biochemical
measurements were considered continuously varia-
ble. For both types of data, the millimolar con-
centration of platinum tetracholoride that yielded
a 50% response for any test parameter was ob-
tained through inverse prediction of the simple
regression line. Analysis ofvariance was employed
to determine the significance ofdifferences between
DNA and total protein determinations in standar-
dizing uptake and incorporation data.
Results
The washed, unsized particles ofplatinum diox-
ide were actively phagocytized by rabbit alveolar
macrophages over a 20-hr exposure period by
microscopic observation but did not cause cell lysis
or alter cell viability as determined by trypan blue
exclusion tests. Concentrations as high as 500
Ag/ml ofculture medium were without effect on the
cells (Table 1).
Table 1. Effect of platinum dioxide on viability and num-
bers of rabbit alveolar macrophages after 20 hr.
No. of PtO2 Cell number, Viability
cultures jxg/ml Viability, % % of control indexa
7 0 96.6(± 1.13)b 100(± 13.5)b 97.3(± 13.2)b
2 100 96.5 120.6 116.4
2 200 95.5 87.7 83.3
4 500 95.7 ( 2.21)b 89.6 (± 21.4)b 84.9 (± 19.3) b
aSee text.
b± S.D. given in parentheses
Atomic absorption spectrophotometry indicated
that very little platinum (< 0.2 ug/ml) was present
in the test medium after a 20-hr incubation at a
concentration of platinum dioxide of 500 ,tg/ml.
This determination was accomplished after parti-
cles of platinum dioxide were removed by passing
the medium through a 0.22 ,m porosity membrane
filter. Platinum tetrachloride was relatively solu-
ble in the test medium, so that 60-80% of the
available platinum was released in soluble form
(i.e., could not be removed by filtration) within 30
min to 1 hr.
Rabbit alveolar macrophages exposed to
platinum tetrachloride for a period of 20 hr in three
experiments exhibited a 50% reduction in cell
viability at an estimated concentration of 0.40mM
or 78,ug Pt/ml (Fig. 1A).
Platinum tetrachloride was not markedly
cytolytic for alveolar macrophages (Fig. 1B) as evi-
denced by the factthat cell numbers decreased only
slightly over the concentration range that caused
reduction in cell viability. Erratic determinations
of cell numbers are believed to be due to clumping
of macrophages which was noticeable at cytotoxic
concentrations.
When estimates of cell viability in cultures ex-
posed to platinum tetrachloride for 20 hr were cor-
rected for the slight decrease in cell numbers over
this period, the resultant figure was termed the
viability index (cf. Materials and Methods). The
curve for viability index as a function ofconcentra-
tion of platinum tetrachloride is shown in Figure
1C. A 50% reduction in viability index after 20 hr
was observed at a platinum tetrachloride con-
centration of 0.30mM or 59 ,ug Pt/ml.
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FIGURE 1. Effect ofplatinum tetrachloride on (A)viability, (B)
cell numbers, and (C) viability index in rabbit alveolar
macrophages after 20 hr. Each point represents one culture.
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FIGURE 2. Platinum tetrachloride effect on (A) total ATP per
106 cells and (O) phagocytic activity in rabbit alveolar
macrophages after 20 hr. Each point represents the mean of
two cultures.
A reduction in phagocytic activity and a
decrease in total adenosine triphosphate (ATP)
was observed at concentrations of platinum
tetrachloride lower than those which caused loss of
cell viability as illustrated in Figure 2. Concentra-
tions of platinum tetrachloride which caused a
reduction in ATP and phagocytic activityto 50% of
control after 20 hr were 0.25mM (48,g Pttml) and
0.21mM (41 ,ug Pt/ml), respectively.
Additional studies on platinum tetrachloride
dealt with the strain WI-38 human lung fibroblast.
In the fibroblast system, the concentration
which caused a reduction in cell viability to 50%
after a 20-hr exposure was 0.79mM or 154,ug Pt/ml
(Fig. 3A). After a 20-hr exposure the compound was
determined to be lytic or, more likely, growth in-
hibitory for human lung fibroblasts. The effective
concentration which resulted in a 50% reduction in
cell number after 20 hr was 1.03mM or 201 ,ug
Pt/ml (Fig. 3B). The net effect of loss in viability
and lysis or growth inhibition in strain WI-38
human lung fibroblasts (Fig. 3C) was to reduce the
netnumber ofviable cells orviability index after 20
hr to 50% of control levels at a platinum con-
centration of 0.42mM (82 Ag Pt/ml). This con-
centration compares favorably with the figure of
0.30mM (59,g Pt/ml) which resulted in a viability
index of 50% with alveolar macrophages (Fig. 1C).
As in the case ofthe macrophages, total ATP per
million cells (Fig. 4) was depressed at a lower con-
centration after 20 hr than that required to alter
cell viability. The effective concentration which
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FIGURE 4. Total ATP per 106 cell in strain WI-38 human lung
fibroblasts exposed to platinum tetrachloride for 20hr. Each
point represents one culture.
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FIGURE 3. Influence ofplatinum tetrachloride on (A) viability,
(B) cell numbers, and (C) viability index in strain WI-38
human lung fibroblasts after 20 hr. Each point represents
one culture.
caused a reduction in total ATP to 50% of control
was O.11mM or 22.5,ug Pt/ml.
Subsequent studies were performed to determine
the effect of platinum tetrachloride on the uptake
and incorporation of 14C-labeled precursors of
DNA, RNA, and protein synthesis. Rapidly grow-
ing cultures (Fig. 5) were exposed for up to 22 hr to
platinum tetrachloride at concentrations ranging
from 0.0007mM (0.14 ,ug Pt/ml) to 0.14mM (27 jig
DAYSAFTER SEEDING
FIGURE 5. drowth curves for strain WI-38 human lung
fibroblasts (o) in passage 22 and (A) in passage 33. The seed-
ing concentration was 1.75 x 105 cells/ml. Note 22-hr period
within rapid growth phase in which experiments described
were performed. Each point represents the mean of two
cultures.
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Pt/ml). Thymidine-2- 14C, uridine-2- 14C, or
leucine-1-14C was then added, to remain for only 2
hr as described under Materials and Methods.
The total uptake of the radioactive precursors
into cells, their incorporation into tissue
macromolecules, and their incorporation into the
perchloric acid (PCA) soluble fraction, was stan-
dardized on the basis oftotal culture protein since,
statistically, after adjusting for scaling factors,
there was no difference in DNA or total protein
content over the concentration range studied (Fig.
6). Platinum tetrachloride did not alter the ratio of
DNA to total protein in human lung fibroblasts ex-
cept at concentrations sufficiently high to reduce
cell viability (> 0.07mM).
As shown in Figure 7, the uptake and the incor-
poration of radiolabeled thymidine, uridine, and
TIME, hours
FIGURE 7. Plots of(left)total cellular uptake of(o)thymidine-2-14C, and (i) leucine-l-l4C and (A) incorporation ofthymidine-2-14C
and (A) leucine-1-14C into PCA-precipitate materials by strain WI 38 human lung fibroblasts as a function of time; (right) total
cellular uptake of (m) uridine-2-14C and (A) incorporation of uridine-2-14C into PCA-precipitable materials as a function of time.
Each point represents one culture.
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FIGURE 8. Inhibitory effect of platinum tetrachloride on (A)
total uptake, (B) incorporation into PCA-precipitable
materials, and (C) incorporation into PCA-soluble fractions
of (o) thymidine-2-14C, (A) uridine-2-14C, and (0)
leucine-1-'4C in strain WI-38 human lung fibroblasts after
22 hr. Radiolabeled precursors were present only during the
last 2 hr ofthe 22-hr total exposure period. Each point repre-
sents one culture.
leucine in control cultures was linear with respect
to time for at least 3 hr. In control cultures, l.ON
PCA-precipitable radioactivity accounted for ap-
proximately 65% of thymidine uptake, 55% of
leucine uptake, and 20% of uridine uptake.
The inhibition of thymidine uptake was ob-
served to occur at significantly lower concentra-
tions ofplatinum tetrachloride than required to in-
hibit uridine or leucine uptake (Fig. 8A). A 50% in-
hibition ofthymidine uptake resulted from a 20-hr
exposure to platinum tetrachloride at a concentra-
tion of0.012mM or 2.3,ug Pt/ml. Higher concentra-
tions by 3.5 and 5-fold were required to inhibit
uridine or leucine uptake, respectively.
The incorporation of radiolabeled thymidine,
uridine, and leucine into PCA-precipitable
macromolecules followed essentially the same pat-
tern as observed for total cellular uptake (Fig. 8B).
A 50% inhibition of incorporation of each
radiolabeled precursor occurred at slightly, but not
significantly lower, platinum concentrations than
required to inhibit total cellular uptake (Fig. 8B).
For example, the incorporation of thymidine into
PCA-precipitable material was 50% inhibited at
0.007mM or 1.4 ug Pt/ml.
The incorporation of thymidine, uridine, and
leucine into PCA-soluble material was determined
by subtraction of the PCA-precipitable radioac-
tivity from the total cellular uptake radioactivity,
both corrected to disintegrations per minute per mg
protein. The curves thus obtained (Fig. 8C) were
quite similar, in that the curve for thymidine incor-
poration into PCA-soluble material had shifted to
the right. The result wasthatthe effective platinum
concentration (0.033mM) for 50% inhibition of
thymidine incorporation into PCA-soluble
material was 4.7-fold higher than that required to
inhibit incorporation into PCA-precipitable
material.
Time-course studies (Fig. 9A) with exposures of
3 and 7 hr indicated that 0.03 and 0.05mM con-
centrations ofplatinum tetrachloride (5.9 and 11.8
,ug Pt/ml, respectively) inhibited incorporation into
PCA-precipitable material almost completely
(85-90% ) within 7 hr. At these concentrations,
uridine incorporation was 40-50% inhibited after
7 hr; leucine incorporation was only 15-25% in-
hibited after 7 hr. The concentration dependence of
the inhibitory effect of platinum tetrachloride on
the incorporation process is illustrated in Figure
9B. It can be seen that higher concentrations of
platinum tetrachloride are required to inhibit
leucine incorporation than are required to inhibit
uridine incorporation. Furthermore, 10-fold higher
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sents one culture.
December 1975concentrations of platinum tetrachloride were re-
quired to inhibit uridine or leucine incorporation
than were required to inhibit thymidine incorpora-
tion after 3 or 7 hr.
The incorporation of 14C-uridine and especially
14C-thymidine into the PCA-soluble fractions (Fig.
9C) was not as rapidly inhibited for given con-
centrations of platinum tetrachloride (0.03 and
0.06mM) as was the inhibition of incorporation of
the same precursors into PCA-precipitable
materials (Fig. 9A). A comparison of Figures 9B
and 9D conveys essentially the same information
with respect to concentration; i.e., that incorpora-
tion of uridine and, to a greater extent, thymidine
into PCA-soluble materials was less inhibited by
exposure to given concentrations of platinum
tetrachloride than was incorporation ofthese same
precursors into PCA-precipitable materials.
The final experiment in this series involved the
removal of platinum tetrachloride after a 4-hr ex-
posure by washing the cultures three times with
supplemented medium (Fig. 10). The recovery of
the processes involving incorporation ofthymidine,
uridine, and leucine was then determined by use of
2-hr pulse labels followed by the harvesting of
replicate cultures 3, 7, and 22 hr after removal of
platinum. The results (for one experiment only) in-
dicated at least partial reversibility of all the in-
hibitory effects of platinum tetrachloride pre-
viously studied except at concentrations suffi-
ciently high to alter cell viability.
Discussion
This investigation demonstrates that rabbit
alveolar macrophages and human lung fibroblasts
are susceptible to the toxicity of soluble platinum
tetrachloride in moderately high concentrations.
Gross manifestations of the cytotoxic response in-
clude changes in cellular morphology with loss in
viability by dye exclusion tests (4). In the
macrophage system cadmium or mercurous
chlorides cause similar effects on cell viability at
one-fourth to one-seventh the concentration re-
quired for platinum tetrachloride (9). However,
platinum tetrachloride is moretoxicthan nickelous
or zinc chlorides in this system by factors of 6 and
10, respectively (9).
Reductions in total ATP levels are observed at
lower concentrations of platinum tetrachloride
than required to alter cell viability. With the rabbit
alveolar macrophage, phagocytic activity, a critical
cell function, is inhibited at platinum concentra-
tions which reduce total ATP levels. Such a rela-
tionship might be expected since phagocytosis is an
energy-dependentprocess. Preliminary results indi-
cate that a number of metallic chlorides including
those of Pt4+ Hg2+, Cd2+, Zn2+, Ni2+, and Cu2+
depress total ATP at concentrations comparable to
those which cause a reduction in phagocytic ac-
tivity (9).
Previous studies with platinum antitumor
agents in vitro suggest that rapidly dividing cells
engaged in DNA synthesis are more likely to ex-
hibit cytotoxic responses to the presence of
platinum salts. Harder and Rosenberg (,3) clearly
demonstrated that cis-Pt(II)(NH3)2Cl2 and cis-
Pt(IV)(NH3)2Cl4 are preferential inhibitors ofDNA
synthesis in human amnion (strain AV-3) cell
cultures. Under the same conditions, these com-
pounds caused lesser and secondary inhibition of
RNA and protein synthesis. The present studies
demonstrate that platinum tetrachloride causes
effects in strain WI-38 human lung fibroblasts
similar to those observed by Harder and Rosenberg
(3) for the above platinum compounds. Clearly, the
inhibition of DNA synthesis by platinum
tetrachloride as measured by the incorporation of
thymidine into acid-precipitable materials is
preferential to the inhibition of RNA and protein
synthesis in terms of both concentration and time.
To account for such an effect, Harder and Rosen-
berg (3) have suggested that the active platinum
species binds directly to DNA so that at low
platinum concentrations only DNA synthesis is
affected. At high concentrations they suggested
that a higher frequency of platinum-induced le-
sions might lead to inhibition of RNA production
and, inturn, protein synthesis. Rosenberg et al. (10)
later found that cis-Pt(II)(NH3)2C12 does, in fact,
bind to nucleoside derivatives. More complex ex-
planations have been proposed to account for the
relatively slow but preferential inhibition of DNA
synthesis in vivo (11) and in vitro (12). Pascoe and
Roberts have recently demonstrated that DNA in-
terstrand crosslinking by cis Pt(II)(NH3)2CI2 ap-
pears to parallel the observed inhibitory effects on
DNA synthesis (13); however, this is not the case
with the cis-Pt(IV)(NH3)2C14 compound (14). The
authors are not aware ofdata on DNA crosslinking
by platinum tetrachloride in whole cells.
The irreversibility ofthe inhibitory effects ofcis-
Pt(II)(NH3)2C12 and cis-Pt(IV)(NH3)2CI4 was
described by Harder and Rosenberg (2) in their
$tudies with human amnion AV-3 cells and by
Howle et al. (15) using the former compound with
phytohemagglutinin-stimulated rat lymphocytes.
These findings were consistent with those ofHowle
and Gale (11), who found DNA synthesis persis-
tently inhibited in Ehrlich ascites tumor cells
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55removed periodically from rats up to 4 days after a
single injection ofcis-Pt(II)(NH3)2C12 at 10 mg/kg.
RNA and protein'synthesis were- inhibited initially
but recovered after 4 days.
Harder and Rosenberg (2) suggest that irreversi-
ble inhibition ofDNA synthesis bythe platinum an-
titumor agents may result from the gradual limita-
tion ofthe passage ofthymidine into the cell and a
slow passage ofplatinum compounds out ofthe cell
such that their two rinses may not efficiently
remove the compounds. The preliminary findings
of the present report (Fig. 10) indicate that the in-
hibitory effects of low concentrations of platinum
tetrachloride on DNA, RNA, and protein synthesis
after a 4-hr exposure can be reversed with careful
washing (thrice) to remove the metal. The apparent
reversibility of the observed inhibitory effects of
platinum tetrachloride effects may be a function of
the strength of binding of the specific platinum
compound to DNA or other intracellular compo-
nents or the effectiveness ofthe washing procedure.
In conclusion, this investigation has demonstr-
ated that platinum tetrachloride possesses biologi-
cal activity at the cellular level comparable to that
ofthe more potent platinum antitumor agents. Ad-
ditional study will be required to define more pre-
cisely the nature of the inhibitory effects of this
compound on cellular biosynthetic processes and to
determine the possible consequences ofthese effects
for the intact animal or man.
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